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IN the course of our studies on cancer anaemia in humans (Lockner, 1960)
it was felt that a clearer insight into the disturbances of body composition and
iron metabolism accompanying cancer could be gained by studying experimental
animals. We therefore studied mice bearing inoculated and spontaneous cancers.
The anaemia in the animals studied was found to be caused by blood dilution;
increased iron storage in the reticulo-endothelial system could not be demonstrated,
nor did the tumour play a prominent role in the elimination of erythrocytes from
the circulation. A preliminary account of this work has been presented (Lockner,
1961 ; Hevesy and Lockner, 1962).
METHODS
Animals and tunourrs
Adult C mice (Swiss albino mice from the Serum Institute in Copenhagen)
and adult C3H mice (kindly supplied by Professor G. Klein, Institute for Tumour
Biology, Stockholm) were used. The animals were fed with Salmonella controlled
mouse pellets (Anticimex No. 210, Stockholm) and water ad libitum.
Some of the C mice were injected intramuscularly into one hind leg with about
2 x 106 freshly taken cells of an Ehrlich ascites tumour strain (ELD (Revesz
and Norman, 1960), kindly supplied by med. cand. U. Norman, Institute for
Tumour Biology, Head: Prof. G. Klein), suspended in 0G ml. sterile saline.
Between 10 and 20 days were allowed for tumour growth. The C3H mice used
consisted partly of females bearing spontaneous mammary carcinomas, partly of
young females without tumours and partly of healthy males. Animals with
ulcerated tumours were discarded.
Radioactivity
59FeC13 (5-20 ,uc/,tg.Fe Oak Ridge National Laboratory) in 3 8 per ceint
ammonium citrate was used. Maximally 0*25 /,uc 59Fe in 0-1 ml. was injected
intraperitoneally into groups of 5 to 10 animals for radioiron distribution studies.
Other groups were quantitatively injected into a tail vein with 0-1 ml. mouse
plasma containing radioiron previously incubated (30 minutes at 370 C.). An
aliquot ofeach radioactive solution injected was set aside to be used as a standard.
At different time intervals after 59Fe injection, groups of 5-10 animals were
killed and the amount of radioactive iron determined in their organs. In this
way the percentage of the administered as well as of the recovered radioiron wasSTUDIES ON CANCER ANAEMIA
determined in blood, liver, spleen, kidneys, muscles, skin, skeleton, tumour and
residual organs (all organs except those mentioned). To make it possible to
distinguish between radioiron contained in the constituents of an organ and radio-
iron in the blood remaining in this organ at the death of the animal, the circulating
blood of the mice was counterlabelled with 5'Cr-labelled mouse erythrocytes of
the same strain 15 minutes before killing the animals, this procedure giving at
the same time the blood volume of the animals. The donor erythrocytes were
washed with ACD-solution, incubated with Na251CrO4 (10-140 /cC/ltg. Cr) for
one hour at room temperature, washed three times with ice cold saline and finally
resuspended in their own plasma which had been saved. 0-1 ml. of this erythro-
cyte suspension containing 0.05-10 ,ac 51Cr was quantitatively injected into a
tail vein, and an aliquot was taken as a standard. The animals were killed in
Nembutal narcosis (3-5 mg. intraperitoneally) by exsanguination from the retro-
ocular sinus (using heparin as anticoagulant). The organs were collected, im-
mediately weighed, pooled and wet digested with sulphuric, nitric and perchloric
acids. The skeleton was carefully freed from muscles and dry digested at controlled
temperature in a muffle oven. The ash was several times extracted with 6 N
HC11; no significant iron loss occurred with this procedure. The iron content of
the organ digests was determined with o-phenanthroline (Borei, 1943), their radio-
activity was measured in a well-type scintillation counter (Ekco Ltd., England).
The volume of all samples was identical. The radiations from 5'Cr and 59Fe were
distinguished by pulse discrimination techniques (Weinstein and Beutler, 1955).
Counting was done sufficiently long to keep the counting error under ± 2 per cent.
All measurements and determinations were done on duplicate samples.
For the plasma iron turnover studies, in which 59Fe bound to mouse plasma was
intravenously injected, an effort was made to select animals having about the same
body weight and tumour size. The animals were killed at different time inter-
vals after injection, blood was taken as described, plasma was obtained by
centrifugation, weighed and assayed for radioactivity. One animal served for
one value. The blood volume was taken to be practically identical. Therefore
radioactivity per gram plasma was plotted directly in correlation to time oIn
semilogarithmic paper for calculation of plasma iron half-time.
To be able to study cohorts of cells furnished in a short time interval, reutilisa-
tion of radioiron from destroyed erythrocytes and recirculation of radioiron
from organs was blocked by injection of inactive iron. Healthy and tumour-
bearing C mice were first injected intraperitoneally with radioiron. Starting with
the first day after radioiron injection inactive iron was given (Ferrigen kindly
supplied by Astra, Sodertalje) by the intraperitoneal route, 1 mg. daily per mouse.
At suitable intervals groups of 5 to 10 animals were exsanguinated. Haemin was
prepared from their blood by the acid-acetone method (London, Morell and
Kassenaar, 1960), three times purified, wet digested and the specific iron activity
determined as described.
In a long term experiment 59Fe was injected intraperitoneally into 10 C
mice. After 97 days the animals were killed by exsanguination and the radioiron
distribution determined. From part of the pooled blood, haemin was prepared
as described, and from part of the pooled livers and muscles ferritin and haemo-
siderin were isolated (Gabrio, Shoden and Finch, 1953; Loftfield and Bonnichsen,
1956; von Ehrenstein and Lockner, 1959), wet digested and the specific activity of
the iron contained in them determined.
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Blood values
Haematocrit was determined as microhaematocrit by takinig the blood
directly from the retroocular sinus of the mice. Haemoglobin was measured as
cyanmethaemoglobin in a Beckman DU spectrophotometer. Standardisation
was done with Acuglobin (Ortho Pharm. U.S.A.). Plasma iron was determined
according to Ramsay (1958). All blood values were determined in duplicate.
All experimental values are, ifpossible, given as the mean value : one standard
deviation of the mean. The significance of the difference between two mean
values was calculated making use of variance analysis according to Bonnier and
Tedin (1940).
RESULTS AND DISCUSSION
Organ weights
The body and organ weights from C3H mice bearing spontaneous mammary
carcinomas and from C mice bearing inoculated solid-growing Ehrlich ascites
tumours and their respective controls are given in Table I and II. As the
spontaneous mammary carcinomas ofthe C3H mice develop only in female animals
and nearly 100 per cent of all females get tumours, it is difficult to find enough
female controls of suitable weight and age. We succeeded in studying 7 such
animals and their data are given together with those of 19 healthy males and 33
tumour-bearing females (Table I). The difference between the sum of the organ
weights and the body weight given in the tables is due to blood taken from the
animals when killing them.
Cancerous and control groups of C mice held the same mean weight when the
tumour was injected and they still hold it when a 1 g. tumour has developed
(Table II). This means that these animals feed up their tumours at the expense
of their other body constituents, not by directing an eventual higher nutrient
intake to develop the tumour as an extra organ (cf. Begg, 1958). The body
weight of the cancerous C3H mice is higher than that of both control groups
(Table I), which show no difference between each other. When however the
tumour weight is subtracted from the body weight of the cancerous C3H mice
all three groups hold equal weight. This fact makes a comparison between
cancerous and control animals very suitable (Table I).
The liver and spleen weights ofthe cancer-bearing animals ofboth groups show
a pronounced increase. The kidney weights of the cancer-bearing C mice were
not changed, nor were those of the cancer bearing C3H mice compared to their
female controls, while the male controls had a significantly higher kidney weight.
The residual organs were unchanged in weight in cancer-bearing C mice, whereas
they were lower in cancer-bearing C3H mice compared with both control groups.
Skin weight was increased in cancer-bearing C mice and unchanged in C3H mice.
Muscle weight was unchanged in both groups, only the male C3H mice showed a
higher value. The weight of the skeleton was lower in both cancer groups
(Table II).
The findings on liver and spleen weight confirm those of earlier investigators
(cf. Begg, 1958; Andreini, Drasher and Mitchison, 1955; von Ehrenstein,
1958a; Rigby et al., 1962; Woodruffand Symes, 1962). One ofthe main reasons
for the increase in liver and spleen weight found in our animals seems to be a
massive plasma cell orlymphocytic infiltration and reticulo-endothelial hyperplasia
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TABLE II. Mean Values ± One Standard Deviation of Total Body and Organ
Weights from 50 Healthy Male C Mice and 26 Male C Mice bearing Solid-
Growing Ehrlich Ascites Tumours. Statistical Significance of the Difference
between the Mean Values is Given
Controls Cancerous Significance
g. g. of difference
Total body ±304-3 3123-4 . pbO 2
Liver . 1-658±0264 1-974±0-234 0 -001 >p
Spleen 0-155±0075 0-291 ±0-073 . 0 001 >p
Kidneys 0.482±0096 0.466±0i047 p>0*2
Residual organs 6 994±1-600 6-792±0 939 p>02
Skin . 5-182±1019 5-931 ±0-582 0 001>p
Muscles . 7-826±1-350 7-705±1-170 p>02
Skeleton 6-570±1-128 6-06241-330 0 2>p>0-O
Tumour 1-036+ 0 382
in both organs, seen on histological examination.* Similar or identical results were
obtained by other investigators (cf. Begg, 1958; von Ehrenstein, 1958a; Baruah,
1958; Sandberg, Woernley and Crosswhite, 1959; Friedell, Sherman and
Sommers, 1960; Rigby et al., 1962). The eventual contribution of the increased
amounts of erythropoietic tissue, which were seen by the microscope, to the
weight increase in these organs is discussed later. The fact that the changes
found in liver and spleen weight and their histological appearance are identical
in tumour-bearing C3H and C mice suggests that they are not caused by the
inoculation of foreign cancer cells, as could be the case for the C mice (cf. Old
et al., 1960).
The growth-impulse to the spleen seems to be transmitted by the blood, as
it is possible to cause an increase in spleen weight by injecting blood from cancerous
animals into healthy ones (Crossley et al., 1955; von Ehrenstein, 1958a; Stansly,
Ramsay and Nielson, 1962). There seems, on the other hand, to exist a correlation
between the amount of necrotic tissue in a tumour and the increase it causes
in spleen weight (Sherman and Patt, 1956), while the effect on liver weight is
usually slight or absent. The spleen weight was found to correlate significantly
(001 >p>0 001) with tumour weight, but not the liver weight. In human
subjects who had died from cancer no general increase in liver or spleen weight
could be found (Calo, 1932; Muller, 1932; Hevesy, unpublished observations),
which is possibly explained by the cachexia usually accompanying heavy cancer
growth. The same is true for animals that die spontaneously from cancer (cf.
Begg, 1958; von Ehrenstein, 1958a).
The decrease of kidney weights in tumour-bearing C3H mice found by von
Ehrenstein (1958a) seems to be a sexual difference, as we have found it too when
we compared cancerous females with male controls, but not in comparison with
female controls. Nor did C mice of identical sex show any difference.
The reduction in weight of the residual organs of the cancer-bearing C3H
mice seems to be due to loss of fat (cf. Begg, 1958) from the attachments of the
intestines, the guts contributing the biggest part in weight to the heading " residual
organs The absence of any change in the C mice group may be due to the
considerably smaller size oftumour and its shorter time ofgrowth in these animals.
We have no explanation for the increase in skin weight in the cancer-bearing C
* Thanks are due to Prof. G. Haggqvist, Stockholm, for interpreting the histological sections of
the mouse organs.
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mice. Thehigher muscle weight in the male C3H mice is probably a sex difference.
The lower skeleton weight in both cancer groups may possibly be caused by
osteoporosis, but no experimenits were done to confirm this explanation.
Haematological data
The haematological data for both groups of mice are shown in Tables III and
IV. It can be seen from the haemoglobin concentration and haematocrit values
that the cancer-bearing animals of both groups are anaemic. The difference
between cancerous and control values is highly significant. The blood volume is
significantly and markedly( 30 per cent) increased in both groups of cancerous
animals. This increase is due solely to an increase in the plasma volume, which is
highly significant, whereas the erythrocyte volume is unchanged. As a conse-
quence the cancerous animals of both groups have an unchanged total haemoglobin
content. The mean corpuscular haemoglobin concentration (MCHC) is in both
groups unchanged, which means that the anaemia is normochromic.
Price and Greenfield (1958) have pointed out that part of the reported changes
of blood volume in cancerous individuals may be caused by loss of weight induced
by the growth of cancer, and that correction for this loss tends to change these
values to normal ones. The unchanged body weight of the cancerous C mice in
spite of a1 g.growth could at least in part be caused by fat loss. On the other
hand it is questionable if the badly vascularized tumour tissue in both types of
cancers studied has a higher blood content than fat. So, for example, the mean-
sized tumour in our C3H mice comprises nearly 20 per cent of their body weight.
We consequently conclude that weight changes are ofminor importance in bringing
about the blood volume changes in the animals studied by us. As, at the same
time, a normal total haemoglobin and erythrocyte volume in combination with
a heavy increased plasma volume are found, we must call this anaemia a dilution
anaemia.
TABLE IV. Mean Values ± One Standard Deviation ofHaemnatological Data from
35 Healthy Male(1 Mice and 35 male C Mice Bearing Solid Growing Ehrlich
Ascites Tumours. Statistical Significance of the Difference Between the Mean
Values is given
Degree of
Controls Cancerous significance
Haeinoglobin conc. g. percent 13- 6±09 11* 4±27 . O*001 >p
Haernatocrit percent 44* 1 ±2 7 36* 9±8 2 0 O 001X>p
Bloodvolumeml. 2-1±0 3 2-7±0 6 . O 001 >p
Plasinavolumemi. 1*185±0 19 1 69 ±0-46 . O*001 >p
Erythrocyte volume ml. 093±0-13 096±0i 24 p>O*2
Total haemoglobin ing. 282 ±32 303 ±23 O*2>p>O.05
MICHC percent 309-117 . 305±22 p>02
Taylor (1945) found that haemoglobin concentration decreased more rapidly
than total haemoglobin fell, at the same time as the blood volume increased in
his cancer-bearing mice; but these animals did not show a constant total haemo-
globin. The author used however only a semiquantitative method to determine
the blood volume. Others (Sobel and Furth, 1948; Reilly, Helwig and Scott,
1956; van Ebbenhorst-Tengbergen and MPhlbock, 1958; von Ehrenstein,
1958b) found in mice and rats the same as we did. Similar results were obtained
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in patients with cancer of the uterine cervix (Lockner, 1960), while the values in
other types of cancer differ (cf. Price and Greenfield, 1958).
Practically nothing is known about the underlying causes of the plasma
volume increase in cancerous animals. In contrast to Sobel and Furth (1948)
a decrease in plasma protein concentration in cancerous animals was found by
us (Hevesy and Lockner, 1962), as by others in humans (Bodansky, 1956;
Hammer, 1961). Rechcigl, Grantham and Greenfield (1961) demonstrated a
higher intake of water and NaCl in tumour-bearing rats, which would partly
explain the decreased plasma protein content. One is therefore inclined to
seek the disturbance leading to plasma volume increase in the cancerous animals
in mechanisms regulating sodium chloride excretion, such as an increase of aldo-
sterone secretion or related mechanisms (cf. Moore, 1962).
Hb Ht
g% %
Hb
15 0 50- *_
120 40
11-5
9-0 30-
7.5
6 0 20-
1 2 3 4 6 8 10 12 14 16 18 20 22 24 26 28 3O Days
FiG. I. Haemoglobin concentration and haematocrit values firomn cancer-bearing C mice3
at different time intervals after tumour inoculation. Each point represents the mean of 5
aniinals.
These results raise the question why the organism does not compensate for
this blood dilution by an increased production of haemoglobin. Erslev (1955)
showed in rabbits that artificial blood dilution did not increase erythropoiesis.
The same seems to be the case in our cancerous mice. As will be discussed, the
the life span of the erythrocytes in these animals is shortened and erythropoiesis
increased. This increase leads to a complete compensation for the increased
erythrocyte destruction, in that the total haemoglobin is kept normal; no com-
pensation however is achieved for the blood dilution. Decreased haemoglobin
concentration caused by an expanded plasma volume does not seem to be an
adequate stimulus for erythropoiesis. Here the necessary oxygen supply to the
tissues is obviously secured by haemodynamic adjustments.
Belcher and Simpson (1960) described sudden haemoglobin falls in rats bearing
inioculated tumours when the tumour was only the size ofa pea. As the underlying
mechanism the authors discovered destruction of a large part of the circulating
erythrocytes, possibly caused by a virus which could be transferred to other,
non-tumour-bearing, animals. We were interested to see if this mechanism was
in operation in our animals too. 160 C mice were injected with Ehrlich ascites
tumour as described and at daily intervals, starting the day after tumour inocula-
tion, groups of 5 animals were killed and haemoglobin concentrations as well as
haematocrit values were determined. The blood volume was determined 14
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and 26 days after tumour inoculation in 10 mice each by means of 51Cr labelled
mouse erythrocytes. Fig. 1 shows the haemoglobin concentration and haematocrit
values. As can be seen, no sudden fall could be observed. The blood volume
two weeks after the start of the experiment was 2*85 ± 0-20 ml. (SD) and at 26
days after cancer injection 3.10 + 0U51 ml. (SD) ; at this time the tumours of the
10 mice in which the blood volume was determined had a mean weight of 9-73 g.
After the 30th day of the experiment the tumours started to ulcerate and bleeding
occurred; this was accompanied by a heavy fall in haematocrit and haemoglobin
concentration not indicated in the curve.
The continuous character of the decrease in haemoglobin concentration with
growth of the tumour is further emphasised by the fact that haemoglobin con-
centration correlates with the tumour weight in all C mice studied with a signifi-
cance of 0*05>p>Q001and for the C3H mice with O001>p. Thus no mechanism
as described by Belcher and Simpson (1960) seems to operate in our animals.
BLOOD
- CONTROL
i~70- ---CANCER
Ln ~~ -0MI | CH-MC
60 I
50 I
40 I
30 I
C- MICE I C3H-MICE
20
10-
6h. 3 days 15 days 97days 6h. 3days 7days 15 days 39 days
TIME AFTER 59 FeINJECTION
Fic(-. 2.-Percentage of 59Fe recovered incorporated into circulating erythrocytes from cancer-
bearing C3H and C mice and their respective controls at different time intervals after radio-
iron injecton. Each point represents the mean of 6 to 10 animals
Radioiron distribution
li these and all the other experiments reported on radioiron distribution,
mice which were always in about the same state oftumour development at varying
intervals after radioiron injection, were studied.
Blood
Radioiron incorporation into the circulating erythrocytes of tumour-bearing
(13H and C mice and their respective controls is shown in Fig. 2. Blood taken
6 hours after tracer application was corrected for plasma radioactivity. At the
later points no plasma radioactivity could be measured. It can be seen that the
tumour-bearing mice incorporate more radioiron into their erythrocytes than
their respective controls. Furthermore, the curve of the cancerous C3H mice
shows an early radioactivity peak at 3 days after radioiron injection. The cancer-
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ous C mice do not show this phenomenon. Iflhowever the reutilization ofradioiron
liberated from destroyed erythrocytes and the continuous release of radioiron
from previously activated iron depots are blocked by the injection of inactive
iron and, for greater accuracy, the activity of purified haemin is measured, then
even the cancer-bearing C mice show this early peak in the blood radioactivitv
compared with their controls (Fig. 3).
The higher incorporation of radioiron into the blood of cancer-bearing as
compared with control mice indicates that the cancer mice direct a bigger part
of their plasma iron into the circulating erythrocytes. This means that cancer
mice make more haemoglobin than control mice; their erythropoiesis is increased
in order to compensate, as will be shown later, for increased red blood cell destruc-
tion. Similar results were obtained by others (von Ehrenstein, 1958b ; Moore
et al., 1961 ; Otsuji, 1962).
Z' 60- 0 0
0 %
50 * *~0 0 * I
40 * I 0__ _ _
30-
20 l
CONTROL 0 CANCER
10-
2 4 6 8 10 12 14 16 18 2 4 6 B 10 12 14 days
TIME AFTER 59Fe INJECTION
FIG. 3. Specific activity of purified blood haemin from tumour-bearing C mice arid control
C mice at different time intervals after radioiron injection. To block radioiron reutilization
daily intraperitoneal injections of 1 mg. inactive iron were given.
Similar early peaks of blood radioactivity as reported here were found by
Berlin, Lawrence and Lee (1951) in polycythaemic humans, by Berlin and Lotz
(1951) in rats and by Neuberger and Niven (1951) in rabbits repairing bleeding
anaemias, followed in later years by many more observations. von Ehrenstein
(1958b) in studying the same mouse tumours as we did by means of [2-14C] glycine
came to identical conclusions. These findings must be interpreted as part of the
cells furnished with the label decaying earlier than the bulk of the erythrocytes,
thus representing a short-living erythrocyte population. Except that these
populations were observed under conditions ofstimulated erythropoiesis not much
more is known about them. It is not even known with certainty if the normal
human or animal produces naturally short-living erythrocytes, which we have
no method to demonstrate unequivocally vet (London et al., 1950; Evans, 1954;
Ambs, 1960).
Skeleton
The bone constituents being relatively stable, the changes in non-circulating
radioiron activity with time in the skeleton in these experiments are considered
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to reflect merely bone marrow radioactivity. As shown in Fig. 4 the bone marrow
contains between 9 and 18 per cent noncirculating radioiron 6 hours after radioiron
administration. Cancer bearing C3H as well as C mice exhibit much lower values
than their respective controls. At subsequent observation points all values
decline, the cancer curve always lying under the control curve. At the end of
the observation period some increase ofthe skeleton radioactivity was again noted.
At 6 hours after radioiron injection between 10 and 35 per cent ofthe radioiron
recovered is already incorporated into the circulating erythrocytes. Thus a big
portion of the radioiron has already, after entering the bone marrow by way of
the plasma, left it again incorporated into erythrocytes. A better picture of the
dynamic state of the blood compartment at this moment is therefore given if we
add blood and bone marrow figures at 6 hours after radioiron injection. At
this time C3H controls contain about 24 per cent and C3H cancers 33 per cent
recovered radioiron in these organs. Nearly 30 per cent more radioiron is thus
BONE MARROW
U." 20 - CONTROL
1S- --- CANCER
10 C _ MICE_C3H-MICE
-0~~~~~~~~~~~~~
6 h. 3 days 15 days 97days h 3days days 15 days 39 days
TIME AFTER 59Fe INJECTION
Fi'c,. 4.- Percentage of 59Fe recovered as noncirculating radioiron in the bone marrow fiom
tumour-bearing C3H and C mice and their respective controls at different time intervals
after radioiron injection. Each point represents the mean of 6 to 10 animals.
(lirected to blood production in the cancerous animal. A similar relationship
exists in the case of C mice as can easily be seen from the blood and skeleton
figures. These findings, as well as the heavier decay ofboth cancer skeleton curves
as compared with their controls, are signs of the increased erythrocyte production
in the cancerous animals.
The later increase in the bone marrow curves may have two explanations.
One is the destruction of erythrocytes, with the radioiron liberated from their
haemoglobin recirculating or directly laid down (von Ehrenstein and Lockner,
1959) in the bone marrow. The other is the slow redistribution of radioiron
previously laid down in the depot organs. As the bone marrow of the cancerous
animals is emptied more completely of iron by the increased erythropoiesis,
in spite of a higher destruction rate of the erythrocytes in the cancerous animals,
less radioiron remains there.
Liver
The change in the concentration of noncirculating radioiron in the liver of both
groups of animals with time is shown in Fig. 5. The curve of the cancerous C3H
mice lies considerably lower than that of their controls ; the cancerous C mice show
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some tendency to be lower still. The liver ofthe' cancerous mice however has a mean
weight increase (cf. Tables I and II) of about 15 per cent. Taking these facts in
combination we can state that the total as well as the specific uptake of radioiron
into the liver is considerably lower in cancer-bearing animals than in controls.
This is in contrast to the reticulo-endothelial hyperplasia seen in this organ.
Similar results were obtained by von Ehrenstein (1958b). In C3H mice a certain
fall ofthe radioiron with time can be observed, which is possibly due to redistribu-
tion of iron. No such fall can be seen in the C mice. Both control curves show
Ino fall in activity between 6 hours and 3 days, which could be indicative oferythro-
poiesis going on in the liver. Such a fall is however observed in the curves of the
cancer-bearing animals, though the decrease is so small that it may only be caused
bv biological and experimental variations or bv redistribution of iron.
LIVER
CONTROL
CANCER
C - MICE C3H- MICE
15-
U,)OS10S\oo
5-- - t~--
6h. 3 days 15 days 97days 6 h. 3days 7 days 15 days 39 days
TIME AFTER 59Fe INJECTION
FIG. 5.- Percentage of 59Fe recovered as noncirculating radioiroln in the liver of tumour-
bearing C3H and C mice and their respective controls at different time intervals after
radioiron injection. Each point represents the mean of 6 to 10 animals.
Spleen
As shown in Fig. 6, the spleen of the cancerous ainimals of both groups contains
more noncirculating radioiron than the control spleen throughout the whole
experiment. After a steep fall, between 6 hours and 3 days, of cancer and control
spleen, the radioactivitv remains at very low values, with a slight tendency to
increase after 39 days.
From plasma iron turnover studies, which will be discussed later, we knom
that the primary distribution of radioiron is finished after a few hours. So that.
if all erythrocytes were made in the bone marrow, the decrease in radioiron there
should be followed by a corresponding increase in blood radioiron. Comparing
the values between 6 hours and 3 days we find that at least twice as much iron is
accumulated in the erythrocytes as is leaving the bone marrow in the same time
iiiterval. This discrepancy can be explained in two ways. One is that radioiroin
is redistributed from other organs and passes the bone marrow without our being
able to see it. Organs releasing iron are shown to be the liver, skin, residual organs
aiid muscles. Another possibility is that erythrocytes are furnished at extra-
medullary sites. This is histologically proven for the spleen of the mouse (Jacob-
son et al., 1950). The early decav in radioiron activity in the control animals is
339D. LOCKNER, K. SLETTEN AND G. DE HEVESY
good evidence for effective erythropoiesis going on in this organ. The 6 hour
radioiron uptake of the cancerous spleen is higher by about 10 per cent than the
corresponding control values; the early decay runs parallel to them. This would
mean that the cancerous spleen shows a somewhat increased erythropoiesis.
On histological examination an increase in erythrocyte precursors inthe cancerous
spleen as compared with control spleen can in fact be seen. Consideringhowever
that the weight of the cancerous spleen is increased by more than 100 per cent its
specific erythropoietic activity is thus calculated to be decreased by about 50
per cent. That means that this accessory erythropoietic tissue is not very effective
in making erythrocytes. The weight increase already discussed is mainly due
to this tissue and the other cell elements already described. This fact helps us to
understand why the later horizontal part of the spleen curve runs considerably
SPLEEN
CONTROL
CANCER
o, ~ t C - MICE C3H- MICE
5- \\\
6h. 3days 15 days 97days 6h. 3days 7days 15days 39days
TIME AFTER 59Fe INJECTION
Fic(. 6. -Percentage of 59Fe recovered as noncirculating radioiron in the spleen of tumour-
bearing C3H and C mice and their respective controls at different time intervals after radio-
iron injection. Each point represents the mean of 6 to 10 animals.
higher than the control curve. There may already be increased erythrocyte des-
truction a short time after radioiron injection, but because of the early horizontal
part of the curve it is more convincing to interpret it as an increased iron storage
in the enlarged spleen. The slight increase in radioactivity occurring at the end
of the observation period may however be caused by accumulation of decaying
erythrocytes.
Skkin, residual organs, mnscles and kidneys
The changes in noncirculating radioiron with time in skin, residual organs,
and muscles are shown in Fig. 7. It can be seen that each of these organs is
nearly as effective in storing radioiron as the liver. Nearly all cancer curves run
somewhat lower than the control curves, especially if we allow for weight differ-
ences, which indicates that more iron is used for erythropoiesis in the cancerous
animals. The steep early fall as seen in most ofthe curves could indicate erythro-
poiesis, but as no erythropoietic function is usually associated with these organs
we consider it indicates redistribution of depot iron. The late increase observed
in some of the curves seems to be caused by destruction of labelled erythrocytes
occurring in these organs or uptake of iron liberated from erythrocytes destroyed
in other organs.
The kidneys never contain more than 2 per cent of the recovered radioiron
and do not show any changes in their radioiron content.
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Tumours
The content of noncirculating radioiron in spontaneous mammary carcinoma
tissue from C3H mice at different intervals after radioiron injection is shown in
Fig. 8. The upper curve shows the measured radioactivity in the different experi-
ments carried out, the irregularity of the curve being due to variation in tumour
size. The middle curve shows the tumour radioactivity calculated for the mean
tumour weight of the C3H mice in all experiments, which is 4 07 g. The lower
curve shows the specific activity of the noncirculating tumour iron.
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FIG. 7.-Percentage of 59Fe recovered as noncirculating radioiron in skin, residual organs and
muscles of tumour-bearing C3H and C mice and their respective controls at different time
intervals after radioiron injection. Each point represents the mean of 6 to 10 animals.
Price and Greenfield (1958) have found that the main part of the erythrocytes
destroyed in the cancerous rats and mice studied by them is destroyed and laid
down in the tumour.
It can be seen from the middle curve in Fig. 8 that 7 per cent of the recovered
radioiron is accumulated as noncirculating radioiron in the tumour 6 hours after
injection. As not many labelled erythrocytes can be destroyed in so short a
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time we consider this iroin to have got there via the plasma. In the course of
39 days this accumulation increases to about 18 per cent. That means that about
11 per cent of the recovered radioiron accumulates in the tumour between 6 hours
and 39 days after radioiron injection. There are two possible ways for the radio-
iron to get there: (a) by redistribution, via plasma, of iron taken up by other
organs soon after iron injection, or iron liberated from labelled erythrocytes
destroyed in other organs, (b) bv direct destruction of labelled ervthrocytes in
the tumour tissue.
(a) 20-30 per cent of the recovered radioiron leaves the liver, residual organs,
muscles and skin in the actual time interval by redistribution. As this exchange
takes place via the plasma, and as the tumour takes up 7 per cent radioiron from
the plasma, this redistribution increases tumour activity by 1-2 per cent. The
yz 59Fe in
tumour
20
_n~~~~. 59Fe i 16~~~~~~~~~~~~~~~1i 1 6 __ .07 g tumour
12 / ___ ~ * spec act of
12 ......--- tumour iron
4
6h. 3days7days 15 days 39 days
TIME AFTER 59Fe INJECTION
Fi(e. 8. Percentage of 59Fe recovered as noncirculating radioiron and specific activity of nioni-
circulating tuinour-iron in the spontaneous mammary carcinomas of C3H mice at differenlt
time intervals after radioironi injection. The upper curve gives the values of the individual
experiments, the middle curve is a recalculation of the same values on the ineanl tumour
weight of 4- 07 g. Each point represents the inean of 6 to 10 animals.
life time of the erythrocytes in the cancerous C3H mice is, as will be showin, of the
order of 14-20 days. That means that in the observation period discussed here
(39 days) all erythrocytes are destroyed about twice. As about 70 per cent of
the injected radioiron has been incorporated (via the plasma) into the circulating
erythrocytes, this amount must be redistributed via the plasma again when these
cells are destroyed. As we have discussed above, 7 per cent of the plasma iron is
directly built into the tumour tissue. This means that even 7 per cent of this
70 per cent, that is about 5 per cent radioiron, is by redistribution built into tumour
tissue from iron liberated when all erythrocytes are destroyed once. As this
happens about twice within 39 days, the total amount built in is about 10 per cent.
To these 10 per cent the 1-2 per cent discussed above have to be added. Thus
11-12 per cent of the recovered radioiron could theoretically reach the tumour via
the plasma from redistribution of depot iron and radioiron liberated anld re-
distributed from destroyed erythrocytes. That is just the amount actually laid
down in the tumour in this time interval.
(b) Let us assume that all iron found in the tumour originates from destroyed
erythrocytes laid down there. Greenfield, Sterling and Price (1960) found that
about 1 per cent of the radioiroin deposited in the tumour by means of labelled
erythrocytes leaves it again per day. This loss would amount in the actual case
342STUDIES ON CANCER ANAEMIA
where 11 per cent accumulated in 39 days to about 1 per cent. In total the tunmour
w^ould thus contain 11 + 1 per cent, that is 12 per cent at 39 days. As dis3ussed
above, this 12 per cent accumulated during the life time of two cell populations
containing about 70 per cent of the recovered radioiron. That means that when
one erythrocyte population is broken down about 6 per cent iron is laid in the
tumour, thus about 10 per cent of the erythrocytes destroyed are destroyed in
the tumour if all points discussed under (a) were not right.
Concluding we cannot find that the mechanism proposed by Price and Greeil-
field (1958) is operating to a greater degree in the C3H mice studied by us. A
similar result was obtained in a patient with a cancer ofthe uterine cervix (Hcvesy
and Lockner, 1962) and by others in rats (Belcher and Simpson, 1960) and
hamsters (Rigby et al., 1962).
There still remains however the question of where the erythrocytes are
destroyed in cancerous mice. It can be shown (von Ehrenstein and Lockner,
1959; Hughes Jones, 1961) that erythrocyte destruction in normal rabbits
occurs approximately proportionally to the distribution of the reticulo-endothelial
et
a>05, > C3H-MICE
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6h. 3days 15 days 39 days
TIME AFTER 59Fe INJECTION
FT(,. 9.- -Percentage of59Fe recovered as noncirculating radioironi in 1 g. sp)ontaneous mammary (arcinoma of C3H mice and 1 g. solid growing Ehrlich-ascites tumour of C mice at different
time intervals after radioiron injection. Each point represents the mean of 6 to 10 animals.
.system in the body, the bone marrow playing a very prominent role in this process.
Owing to the reutilization and redistribution processes going on in the type of
experiments described here it is very difficult to draw any definite conclusion.
The curves shown suggest, however, that erythrocyte destruction seems to take
place in bone marrow, spleen, skin and muscles under normal conditions and that
in the cancerous state these organs show about the same behaviour with only
minor quantitative differences, with perhaps additional destruction in the liver too.
The slower increase of the specific activity of the tumour iron as compared
with the middle curve in Fig. 8 shows that, with time, iron of lower specific
activity is laid down in the tumour.
The accumulation of noncirculating radioiron in the solid growing Ehrlich
tumours of our C mice is shown in Fig. 9, compared with that in spontaneous
mammary carcinomas ofC3H mice and calculated per 1 g. tumour weight. It can
be seen that the two curves are practically identical and run horizontally up to
15 days. At 39 days after iron injection the C3H curve increases. We were not
able to study Ehrlich tumours for such a long time, because ulceration and bleeding
occurred from the tumours and the animals died. It is ofinterest that the activity
of both tumours studied in accumulating radioiron is so similar. This suggests
that even in C mice the mechanism which shortens the life time ofthe erythrocytes
in cancerous mice is not mainly cell removal by the tumour.
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Total body distribution
The radioiron distribution between the main body components of control
aind cancerous C3H and C mice is seen in Fig. 10 and Fig. 11. In both cancer
groups the mean tumour weight was taken. It can be seen from Fig. 10 that the
carcass of the tumour-bearing C3H mice contains only about half as much non-
circulating radioiron as the carcass of the control C3H mice. The greater part
of this missing radioiron is found in the blood, a lesser part in the tumour. With
time, some radioiron is shifted over from the blood to tumour and carcass. The
tumour-bearing C mice show a similar picture (Fig. 11) the difference being
however not so pronounced as for the C3H mice. Up to 15 days the tumour-
bearing C mice show no shift of radioiron from blood to carcass or tumour.
g 90 C3H-MICE
0l)
8O
CONTROL CANCER
70-
70 | Blood / o
50-
Carcass 40~~~~~
30-
20- ...'....
Tumour
10-
6h. 3days 15 days 6h. 3days 15 days I5days 39 days
TIME AFTER 59Fe INJECTION
FiG. 10.-Percentage 59Fe recovered as circulating radioiron in erythrocytes and as non-
circulating radioiron in carcass and tumour of cancer-bearing and control C3H mice at
different time intervals after radioiron injection. Carcass means total bodv radioiron
minus blood and tumour-radioiron.
These findings indicate that the main change in the iron metabolism of the
cancerous animal is a shift from depot (carcass) iron to the blood, as a result of
increased erythropoiesis, and partly to the tumour. This result is in contrast
to suggestions made by Heilmeyer and Keiderling (1959) that, in a way similar to
that postulated by them for the anaemia of infection, an activated reticulo-
endothelial system competes for the plasma iron, using it for detoxicating purposes,
thus not leaving enough over for blood production. We have histological evidence
for an activated reticulo-endothelial system, as already discussed, but it does not
seem to be activated with respect to iron-avidity. Analogous results have been
reported by others (Otsuji, 1962 ; Seno et al., 1962).
One could be inclined to interpret the later part of the cancerous C3H mice
curve, where some iron shifts from blood to tumour and carcass, in the sense of
Heilmeyer and Keiderling (1959). But this is not correct, because here we are no
longer studying the initial plasma iron distribution. This false impression is
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caused by the accelerated turnover of the cancerous erythrocytes in contrast to
the slow turnover oftissue iron. That this effect is not observed in cancer-bearing
C mice is due to the shorter observation period corresponding with the longer
erythrocyte lifetime in these mice (vide infra).
C- MICE
,,70-
S602 \ _ _ = I=
Blood~ ~ ~
Boo
50- Carcass ~~ Carcass
20- CONTROL _ CANCER
Tumour
.**
6h. 3days 15 days 97days6h. 3 days I5days
TIME AFTER 59Fe INJECTION
FiG. 11.- Percentage of 5Fe recovered as circulatiiig radioiron in ervthrocytes and as non-
circulating radioiron in carcass and tumour of cancer-bearing and control C mice at
different time intervals after radioiron injection. Carcass means total body radioiron
iminus blood and tumour-radioiron.
Influence of type of radioiron application
In the radioiron distribution studies discussed so far, for quantitative aind
technical reasons the tracer was injected intraperitoneally. It was assumed that
distribution would not differ markedly from administration by the intravenous
route. In order to study eventual differences in distribution connected with the
intravenous route, 6 control C mice were quantitatively injected intravenously
into a tail vein with radioiron bound to mouse plasma and the radioiron distribu-
tion determined after 3 days. The results obtained are compared with a 3-day
experiment on control C mice injected by the intraperitoneal route. The results
are given in Table V without standard deviatioins because the organs were pooled
for technical reasons.
TABLE V.-Percentage of 59Fe Recovered in Circulating Haemoglobin and as Non-
circulating Iron in Different Organs of Healthy C Mice 3 Days After Injecting
Radioiron into 10 Mice Intraperitoneally and into 6 Mice Bound to Plasma
Intravenously
Intraperitoneally Intravenously
per cent per cent
Blood 54-5 62-1
Skeleton 5-0 3-9
Liver 12-2 95
Spleen . 0.0 0o
Kidnevs . 0-2 0-7
Residual organs 17-0 . 6-1
Skin . . 4-9 11-3
Muscles . 6-1 6-3
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When the intraperitoneal route is used, the abdominal organs (liver and
residual organs) contain about 14 per cent more ofthe recovered radioactivity than
the corresponding organs after intravenous administration. This 14 per cent
goes, when the intravenous route is used, in equal parts to the blood and skin
instead.
Thinayothin and Crosby (1962) found that iron-dextran entered the small
intestine via the serosa, being carried by phagocytes. Whether the transferrin-
bound iron used by us is transported by the same mechanism is not known to us.
The fact that we found an increase in liver uptake too, which the authors cited
did not, suggest some difference in mechanism. The higher uptake in the residual
organs explains the steep fall of their activity already discussed as redistribution
but lessens their importance as depot organs. These findings have no implica-
tions on the results presented on the influence of cancer on iron metabolism, as
comparisons were made between equally treated groups.
Difference in radioiron distribution between male andfemale C3H mice
As already discussed, it is difficult to get enough female control C3H mice for
extended studies. Male C3H mice of about the same age and weight as the
cancerous female mice were therefore used as controls in the radioiron distribution
studies reported. In order to see how far this could lead to wrong conclusions,
the radioiron distribution was compared 3 days after intraperitoneal iron adminis-
tration between 4 female and 5 male control C3H mice. The results of this study
are given in Table VI.
It can be seen that the radioiron distribution is practically identical. Tlle
female C3H mice contain less total body iron, even if the weight difference is
allowed for, a fact the importance of which will be stressed below.
TABLE VI.- Percentage of 59Fe Recovered in Circulating Haemoglobin and as Non-
circulating Radioiron in Different Organs of 4 Healthy Female and 5 Healthy
Male C3H Mice 3 Days After Intraperitoneal Application of Radioiron.
Total Body Iron Content, Haemoglobin Concentration, Haematocrit and Body
Weight are given too.
Females Males
Percentage of59Fe recovered in
Blood . . j3. 5 56- 9%
Skeleton 2.00 100%
Liver 14-5o 13-03%
Spleen . 06 4%
Kidneys 0*30% 00%
Residual organs 169% 16-8%
Skin 6-0%
Muscles . 5-900 6-6%
Total body iron 1245 ,ug. 1380 ,ug.
Haemoglobin concentratio 15 -1 g. 0 15-5 g. 00
Haematocrit 490 490%
Body weight 22 g. 23 g.
Iron content and iron loss of healthy and cancer-bearing mice
Tables VII and VIII show the noncirculating iron content of the organs of
tumour-bearing C3H and C mice and their respective controls as well as their
blood iron and total body iron.
There is no siginificant difference in total body iron between cancer-bearing andSTUDIES ON CANCER ANAEMIA
control C mice. The spleen of the cancer-bearing mice contains however signifi-
cantly more iron and the residual organs significantly less than in the control
animals. All other organs studied show no difference, nor does the body weight
of the two groups show any statistical difference. No measurable noncirculating
iron could be found in kidneys and skeleton.
TABLE VII.-Mean Values ± One Standard Deviation of the Noncirculating Iron
Content of the Organs, Blood Iron and Total Body Iron of 10 C Mice Bearing
Solid Growing Ehrlich Ascites Tumours and 35 Control C Mice. No Standard
Deviations for the Cancerous Mice are given as they consisted of One Group
in which the Organs werePooled. The Statistical Significance of the Difference
between Mean Values is given too.
Significance
Controls Cancerous of difference
Blood . 959+109jug. . 1013,ug. . 02>p>005
Liver . 67±12ug. . 58,g. . 02>p>005
Spleen . . 6±5,g. 24jug. . 0.001> p
Residual o-gans . 220+56,ug. 169,ug. . OOl>p>0 001
Skin . 174±79,ug. 142,tg. 02>p>005
Muscles . 149+18 ,g. 155ug. p>02
Kidneys . . None measurable None measurable
Skeleton None measurable . None measurable
Tumour .. 34,g.
Total body iron 1575±124,jg. * 1595,ug. p> 0-2
Bodyweight . 30-9±5-7g. . 33-6+4-5g. . 0 2>p>005
Tumourweight . .. 1327+0.276g.
The increased iron content of the spleen is related to the increased spleen
weight already discussed. Plasma cell infiltration, increase of reticulo-endo-
thelial tissue, effective and ineffective erythropoiesis as well as a possible
increase of erythrocyte destruction in this organ can be named as reasons for this
effect. As the liver weight is increased for similar reasons except for erythro-
poiesis, and as this organ contains a little less iron in the cancerous animals, we are
inclined to seek the reason for the increase in spleen iron mainly in the ineffective
erythropoiesis and partly in the increased erythrocyte destruction going on in
this organ under the influence of cancer. The lower iron content of the residual
organs and the skin of the cancerous animals is in contrast to an increase in
cancerous C3H mice. No explanation can be given for this observation.
The absence of measurable iron in the skeleton suggests that no chemically
measurable iron pool exists in the bone marrow.
In C3H mice we find similar results as in C mice (Table VIII). Some changes
are more pronounced, possibly caused by the greater activity of the tumour in
bringing about metabolic changes typical of the cancerous growth, as it is nearly
four times bigger than in cancerous C mice. Furthermore the development of
the tumour is much slower in C3H than in C mice. Most important here, as in
the earlier comparisons, are the control-female values comparedwiththe cancerous,
as the latter are of female sex too. Even here we can see that in spite of an
increased liver weight no more iron can be found in this organ. Spleen iron is
markedly increased, for reasons already discussed. The residual organs in spite
of decreased weight, and skin, muscles, and kidneys in spite of unchanged weight
show significant increases in their iron content. As a consequence we find a
heavily increased (32 per cent) total body iron in the cancerous group. Even if
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we subtract the tumour iron from the total body iron, thus eliminating the
difference in weight between the groups (total body corr. in Table VIII), the
higher iron content of the cancerous animals is still highly significant (22 per cent)
Neither cancerous nor control C3H mice contain measurable quantities of depot
iron in their bone marrow. It is interesting that residual organs, skin and muscles
contain far more iron than the liver in both cancerous and control mice. When
we combine the data of iron and organ weight given in this paper we are able to
calculate the specific iron content of the different organs. For the C mice we
find that liver and spleen have the highest iron concentration, but only that of the
spleen increases in cancer. The C3H mice data show that here also the spleen
contains the highest iron concentration, a great increase taking place in cancer.
The liver remains relatively unchanged, though marked increases are noted for
residual organs, skin, muscles and kidneys. The tumour of the C3H mice has the
highest iron concentration next to the spleen, but this is only half as much as in
the last mentioned organ. An increase in liver-iron and a decrease in spleen-iron
in cancer was found by others (Yamaguchi et al., 1960).
With regard to the heavily increased iron content of the cancerous C3H mice,
we were interested to know if this increase was achieved by decreased excretion
or increased absorption of iron or a combination of both. By giving radioiron
to an organism and measuring its total radioiron content at different time intervals,
some indication can be obtained of the iron loss occurring in it. Studies were
made with this technique in mice (Stevens et al., 1953; von Ehrenstein and
Hevesy, 1959) and in man (Finch, 1959). Recently the total body counter came
into use for this purpose (cf. Reizenstein et al., 1961). If the loss of radioiron
is to be an indicator of the amount of total iron lost by the organism, the iron given
must mix completely with the body iron. That this is presumably not the case
could be shown by Finch (1959) for the human and is seen from Table IX for the
mouse, 97 days after administration of radioiron.
TABLE IX. Specfic Activities of some Tissue Protein Fractions 97 Days After
Intraperitoneal Radioiron Injection into Control C Mice. Preparations
obtained from Pooled Organs of10 Anirnals
Blood haemin 13 7 counts//min./)ug.Fe Liver ferritin . 139 - ,
Liver haemosiderin 11-4 ,. ..
Muscle ferritin . 18- 8
Muscle haemosiderin . 13- 2 ,, 9
The specific activities of liver haemosiderin, muscle ferritin, and muscle
haemosiderin are considered to deviate significantly from the other values given.
Thus, when the iron is given by injection, radioiron loss from mice merely indicates
loss of labile body iron. By comparing the total amount of radioiron recovered
after different time intervals, in our studies on distribution of radioiron, with the
amount of radioiron injected, we find the percentage loss of labile body iron in
the groups of animals investigated. The curves are given for cancerous C3H
and C mice and their respective controls in Fig. 12. The curves show irregu-
larities, as the values given were always obtained by summing up all the separately
determined organ activities, which necessarily aggravates eventual mistakes.
It can be seen however that the cancerous C3H mice lose considerably more
labile radioiron than all the other groups. This is in contrast to the greatly
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increased body iron content of the cancerous C3H mice and indicates that these
mice must absorb considerably more iron than healthy animals.
Pla8ma iron turnover
Plasma iron turnover was studied in cancer-bearing C3H and C mice and
their respective controls (Table X). The disappearance of trace amounts of 59Fe
from the plasma of cancer-bearing and control C mice showed no difference. A
shorter half-time was however found for the cancerous C3H mice as compared
with their controls. The plasma iron turnover was calculated according to a
modification of Huff's method (Huff, 1960). Plasma iron concentration was
determined in other animals than those used for the turnover studies. It can
be seen from Table X that the plasma iron concentration decreases in cancer,
C3H CANCER
C3H CONTROL
- -C CANCER
U, 100 C CONTROL
S 90,'_\
80 X
70-
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50
40
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6h. 3days7days 15cdays 39 days 97days
TIME AFTER 59Fe INJECTION
FiG-. 12.-Total body radioiron activity recovered at different time intervals afteI radioiroi
injection into control and cancer-bearing C3H and C mice. Each point represents the mean
of 6 to 10 animals.
as has been found by others (cf. Price and Greenfield, 1958). The C mice with
their smaller cancers show a smaller effect. In spite ofan unchanged half-time and
a decreased plasma iron the cancerous C mice are able to increase their iron
turnover. This they do by increasing iron incorporation into their erythrocytes.
In the cancerous C3H mice this mechanism is working along with a shortened
half-time, but is even more pronounced. This is a compensating mechanism
which the human cannot use to this degree, a fact which is discussed in greater
detail by Hevesy and Lockner (1962). The iron turnover calculated per hour per
litre of erythrocytes is, for normal mice, about three times that for humans
(Lockner, 1960), a fact which corresponds well with the three times longer life
span of erythrocytes in humans. By knowing the amount of iron transported in
the plasma per day, and its percentage incorporated into the erythrocytes, we are
able to deduce the amount of haemoglobin synthesized per day (Table X).
Dividing the amount of total haemoglobin present in the circulation by the
amount synthesized per day, the life time of the erythrocytes can be calculated.
The values found for control C and C13H mice correspond quite well with those
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found by voIn Ehrenstein (1958c), who, usinig [2-14C']glycine found values between
40 and 46 days. Even the values for the cancerous mice show good correlation.
voIn Ehrenstein found for TE mice bearing solid growing Ehrlich cancer 26 days;
these tumours were however about twice as big as ours. For cancer-bearing C3H
mice a value of 14 days was found by this author.
It is not possible to calculate from human plasma iron turnover values the
lifetime of human erythrocytes (Pollycove, 1959), because a usuallv unknownl
amount of iron returnis from the bone marrow. It is therefore surprising that
our values, obtained by the iron method, correspond so well to direct determina-
tions. This allows us to conclude that in contrast to the human, no measurable
amounts of iron return from the bone marrow into the plasma, an assumption
which is supported by the fact that we cannot find measurable quantities of
noncirculating iron in the bone marrow, suggesting that Ino measurable " labile
bone-marrow pool" exists in the mouse. Eveni a considerablv smaller amount
would have been detected.
SUMMARY
Organ weights, blood values, 59Fe distributioni and turnover, as well as iron
content were studied in C mice bearing inoculated solid-growing Ehrlich ascites
tumours (ELD) and in C3H mice carrying spontaneous mammarv carcinomas and
in their respective controls.
Liver and spleen weights were found to be significantly increased, but skeleton
weights were decreased in cancerous mice of both groups.
The cancerous mice of both groups showed a normochromic anaemia caused
by blood dilution, as plasma- and blood-volumes were increased, whilst erythro-
cyte volume and total haemoglobin remained unchanged. The anaemia develops
continuously in relation to tumour weight. As the erythrocyte life span is
shortened in these animals, this organism is able to compensate for this shortening,
but not for the blood dilution. Both groups of mice produce an extra population
of short-living erythrocytes under the influence of cancer.
The cancerous mice show a shift of radioiron from carcass to blood in spite
ofain activated reticulo-endothelial system. Muscles, skin and residual organs are
shown to be important iron depot organs besides the liver. It is shown that the
tumours studied are scarcely active in destroying circulating erythrocytes within
their tissues. The isotope studies confirm the erythropoietic function ofthe spleen,
but in spite ofgreatly increased erythropoiesis in cancer this function ofthe spleen
is not much increased.
The iron content of cancerous C3H mice is greatly increased in spite of an
increased iron loss observed in these animals, which indicates considerably in-
creased iron absorption. The increased iron content is laid down in the spleen,
residual organs, skin and muscles.
Plasma iron turnover is increased in cancerous mice. The turnover figures
allow the calculation of erythrocyte life times, giving 41-5 days for control C
mice and 31.2 days for cancerous C mice. The corresponding values for C3H
mice were 49-2 and 19*5 days. These values correspond quite well with those
found by other methods. This finding allows the conclusion that no substantial
amount of iron returns from the bone marrow after being laid down there via the
plasma.
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